CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.
December 6th 2022
I’ve realized that my forgetfulness and business of working multiple jobs through cancer might have actually helped my mental health.
November 29th 2022
Watch Dr. Leif Ellisen, Dr. Dejan Juric, Dr. Beverly Moy and Natasha Mmeje answer questions about unmet needs during the CURE Educated Patient Metastatic Breast Cancer Summit.
November 28th 2022
Watch Dr. Beverly Moy, from Massachusetts General Hospital, discuss addressing breast cancer disparity during the CURE Educated Patient Metastatic Breast Cancer Summit.
November 27th 2022
Watch Dr. Dejan Juric, from Massachusetts General Hospital, discuss therapeutic resistance during the CURE Educated Patient Metastatic Breast Cancer Summit.
November 26th 2022
Watch Dr. Aditya Bardia, Dr. Arielle J. Medford and Dr. Neelima Vidula answer questions about HER2 and triple-negative disease during the CURE Educated Patient Metastatic Breast Cancer Summit.
November 25th 2022
Watch Dr. Neelima Vidula, from Massachusetts General Hospital, discuss the management of triple-negative disease during the CURE Educated Patient Metastatic Breast Cancer Summit.
November 24th 2022
Watch Dr. Arielle J. Medford, from Dana-Farber Cancer Institute, discuss the management of HER2-positive disease during the CURE® Educated Patient® Metastatic Breast Cancer Summit.
November 23rd 2022
Watch Dr. Aditya Bardia, Dr. Seth A. Wander and Dr. Laura M. Spring answer questions about HR-positive disease during the CURE Educated Patient Metastatic Breast Cancer Summit.
November 22nd 2022
Watch Dr. Laura M. Spring, from Massachusetts General Hospital in Boston, discuss treatment in third line and beyond for hormone receptor-positive breast cancer, during the CURE® Educated Patient® Metastatic Breast Cancer Summit.
November 21st 2022
Watch Dr. Seth A. Wander, from Massachusetts General Hospital in Boston, discuss the first- and second-line treatment of hormone receptor-positive breast cancer, during the CURE® Educated Patient® Metastatic Breast Cancer Summit.
November 16th 2022
When patients are aware of cancer disparities, it can empower them to be proactive about their care to close the prognostic gap between races.
November 4th 2022
I had a wonderful time at a recent breast cancer walk, until I got home and found a bracelet with a raunchy saying on it in my survivor’s gift bag.
November 4th 2022
With a little luck and a lot of coordination, I managed to create an excellent and comprehensive cancer care team in the least populated state in the country.
November 2nd 2022
Since I have stage 4 breast cancer, I wanted an oncologist affiliated with a research institution. However, I hated the prospect of frequent long drives for care. Luckily, I got the best of both worlds.
November 1st 2022
When people say. “It’s just $35 to see a specialist,” they miss the entire issue of cancer-related financial toxicity.
October 12th 2022
The Food and Drug Administration granted a priority review to Trodelvy for previously treated locally advanced or metastatic HR-positive, HER2-negative breast cancer.
October 11th 2022
I wish “Pinktober” was more about saving the people who will die from breast cancer and less about pink ribbons and sexualizing the disease.
October 7th 2022
From the death of standup comedian and "Love Goddess" Judy Tenuta to professional sports hall-of-famers discussing their cancer, here’s what’s happening in the cancer space this week.
October 6th 2022
A patient with metastatic breast cancer shares how she learned that her disease was recently reclassified as HER-2 low, and what it was like to first learn about the FDA-approved drug years before she would be prescribed the treatment.
September 28th 2022
On the same day that I learned of my cancer progression, I also found out I had COVID-19. Here’s how I handled that dark period of life.
September 16th 2022
Extra years with my family meant missing out on a free trip granted to patients with cancer who have children under the age of 18 — and I’m OK with that.
September 13th 2022
As “Pinktober” approaches, I’m spreading the message that breasts are not needed to live a full life after breast cancer surgery.
September 10th 2022
Compared to physician’s choice of treatment, Trodelvy improved survival and quality of life in pretreated patients with HR positive/HER2 negative metastatic breast cancer.
September 7th 2022
I’ve channeled my cancer-related anger into advocacy, and made a “living list” of things I want to accomplish.
September 7th 2022
Trodelvy bested chemotherapy for progression-free survival in patients with HR-positive, HER2-negative metastatic breast cancer.
August 30th 2022
I’m giving cancer’s “battle language” an update and focusing my survivorship plan on emotional wellbeing and honesty.
August 22nd 2022
The death of “Grease” star Olivia Newton-John from metastatic breast cancer has triggered discussions about the specifics of the disease. Here, CURE® details what metastatic breast cancer is.
August 17th 2022
A patient with metastatic breast cancer recalls the emotional experience of being among the thousands of attendees who gave a standing ovation in an auditorium in Chicago when the results of the phase 3 DESTINY-Breast04 trial — which recently led to the FDA approval of Enhertu in HER2-low disease — were presented at the 2022 ASCO Annual Meeting.
July 25th 2022
If approved, Enhertu may “redefine how we classify and treat metastatic breast cancer,” according to a representative from the drug’s manufacturer.